Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Glucagon-like peptide-1: a new potential regulator for mesenchymal stem cells in the treatment of type 2 diabetes mellitus and its complication

Fig. 1

Therapeutic perspectives of GLP-1 combined with MSCs in T2DM and Its Complications

GLP-1 modulates MSCs derived from various tissues and organs of the body by means of pre-treatment of MSCs, gene editing, embedding in biomaterials and peptide chain modification. This combination of treatments has been shown to be effective in injuries to the liver, kidneys, heart, lungs, skin and bone

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512